ATE485279T1 - Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden - Google Patents
Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamidenInfo
- Publication number
- ATE485279T1 ATE485279T1 AT06830756T AT06830756T ATE485279T1 AT E485279 T1 ATE485279 T1 AT E485279T1 AT 06830756 T AT06830756 T AT 06830756T AT 06830756 T AT06830756 T AT 06830756T AT E485279 T1 ATE485279 T1 AT E485279T1
- Authority
- AT
- Austria
- Prior art keywords
- benzimidazolylmethylamin
- benzamides
- salts
- preparing
- improved method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005061624A DE102005061624A1 (de) | 2005-12-21 | 2005-12-21 | Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen |
PCT/EP2006/070034 WO2007071743A1 (en) | 2005-12-21 | 2006-12-20 | Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE485279T1 true ATE485279T1 (de) | 2010-11-15 |
Family
ID=37950582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06830756T ATE485279T1 (de) | 2005-12-21 | 2006-12-20 | Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden |
Country Status (23)
Country | Link |
---|---|
US (1) | US7880016B2 (de) |
EP (1) | EP1968949B1 (de) |
JP (1) | JP5317702B2 (de) |
KR (1) | KR101411961B1 (de) |
CN (1) | CN101346355B (de) |
AR (1) | AR058571A1 (de) |
AT (1) | ATE485279T1 (de) |
AU (1) | AU2006326980B2 (de) |
BR (1) | BRPI0620150A2 (de) |
CA (1) | CA2632310C (de) |
CY (1) | CY1111113T1 (de) |
DE (2) | DE102005061624A1 (de) |
DK (1) | DK1968949T3 (de) |
ES (1) | ES2355045T3 (de) |
IL (1) | IL192242A (de) |
NZ (1) | NZ569636A (de) |
PL (1) | PL1968949T3 (de) |
PT (1) | PT1968949E (de) |
RU (1) | RU2425827C2 (de) |
SI (1) | SI1968949T1 (de) |
TW (1) | TWI411608B (de) |
WO (1) | WO2007071743A1 (de) |
ZA (1) | ZA200804198B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
DE102005061623A1 (de) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen |
DE102006054005A1 (de) * | 2006-11-16 | 2008-05-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester |
US8173906B2 (en) * | 2007-02-07 | 2012-05-08 | Raytheon Company | Environmental protection coating system and method |
US7767589B2 (en) * | 2007-02-07 | 2010-08-03 | Raytheon Company | Passivation layer for a circuit device and method of manufacture |
RU2010143901A (ru) * | 2008-03-28 | 2012-05-10 | Бёрингер Ингельхайм Интернациональ Гмбх (De) | Способ получения композиций дабигатрана для перорального введения |
DK2297132T3 (da) * | 2008-06-16 | 2015-05-26 | Boehringer Ingelheim Int | Fremgangsmåde til fremstilling af et mellemprodukt af dabigatran-etexilat |
EP2300431B1 (de) | 2008-06-16 | 2016-01-06 | Boehringer Ingelheim International GmbH | Verfahren zur Herstellung eines Zwischenprodukts bei der Synthese von Dabigatran |
TWI436994B (zh) | 2008-07-14 | 2014-05-11 | Boehringer Ingelheim Int | 製備含有達比加群(dabigatran)之藥物組合物的新穎方法 |
EP2358368A1 (de) | 2008-11-11 | 2011-08-24 | Boehringer Ingelheim International GmbH | Verfahren zur behandlung oder prävention von thrombose mit dabigatranetexilat oder einem salz davon mit verbesserter wirksamkeit gegenüber der herkömmlichen warfarin-therapie |
US8399678B2 (en) | 2009-11-18 | 2013-03-19 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dabigatran etexilate |
CA2792273A1 (en) * | 2010-03-08 | 2011-09-15 | Ratiopharm Gmbh | Dabigatran etexilate-containing pharmaceutical composition |
WO2012077136A2 (en) * | 2010-12-06 | 2012-06-14 | Msn Laboratories Limited | Process for the preparation of benzimidazole derivatives and its salts |
EP2522662A1 (de) | 2011-05-11 | 2012-11-14 | Medichem, S.A. | Dabigatranetexilat und zugehörige Substanzen, Verfahren und Zusammensetzungen sowie Verwendung der Substanzen als Referenzstandards und Marker |
US9273030B2 (en) | 2012-04-02 | 2016-03-01 | Msn Laboratories Private Limited | Process for the preparation of benzimidazole derivatives and salts thereof |
WO2014033693A1 (en) * | 2012-08-31 | 2014-03-06 | Ranbaxy Laboratories Limited | Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate |
US9399616B2 (en) | 2012-10-22 | 2016-07-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of 4-aminobenzoamidine dihydrochloride |
US10077251B2 (en) | 2012-10-29 | 2018-09-18 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the synthesis of Dabigatran Etexilate and its intermediates |
US9533971B2 (en) | 2012-10-29 | 2017-01-03 | Biophore India Pharmaceuticals Pvt. Ltd | Process for the synthesis of dabigatran and its intermediates |
CN103275065A (zh) * | 2013-05-30 | 2013-09-04 | 上海同昌生物医药科技有限公司 | 一种新的生产达比加群酯的方法 |
EP2835370A1 (de) | 2013-08-08 | 2015-02-11 | Medichem, S.A. | Neue Kristalle von Dabigatranetexilatmesilat |
WO2016000230A1 (zh) | 2014-07-03 | 2016-01-07 | 上海医药工业研究院 | 一种达比加群酯中间体的制备方法及中间体化合物 |
CN105461686A (zh) * | 2014-08-25 | 2016-04-06 | 江苏豪森药业股份有限公司 | 制备高纯度甲磺酸达比加群酯晶型的方法 |
CN104987323B (zh) * | 2015-07-10 | 2017-08-22 | 浙江美诺华药物化学有限公司 | 一种达比加群酯的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6087380A (en) * | 1949-11-24 | 2000-07-11 | Boehringer Ingelheim Pharma Kg | Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions |
PE121699A1 (es) * | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
TWI248435B (en) * | 1998-07-04 | 2006-02-01 | Boehringer Ingelheim Pharma | Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions |
US6248770B1 (en) * | 1998-07-09 | 2001-06-19 | Boehringer Ingelheim Pharma Kg | Benzimidazoles having antithrombotic activity |
US6451832B2 (en) * | 1999-12-23 | 2002-09-17 | Boehringer Ingelheim Pharma Kg | Benzimidazoles with antithrombotic activity |
DE19962329A1 (de) * | 1999-12-23 | 2001-06-28 | Boehringer Ingelheim Pharma | Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel |
DK1485094T4 (da) * | 2002-03-07 | 2020-06-22 | Boehringer Ingelheim Int | Doseringsform til oral indgivelse af 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsyre-ethylester eller dets salte |
NL1026498C2 (nl) * | 2004-06-24 | 2005-12-28 | Free Lift B V | Hellinglifteenheid met blokkeerinrichting en blokkeerinrichting bestemd voor hellinglifteenheid. |
EP1609784A1 (de) | 2004-06-25 | 2005-12-28 | Boehringer Ingelheim Pharma GmbH & Co.KG | Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen |
DE102005061623A1 (de) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen |
-
2005
- 2005-12-21 DE DE102005061624A patent/DE102005061624A1/de not_active Withdrawn
-
2006
- 2006-12-20 CA CA2632310A patent/CA2632310C/en active Active
- 2006-12-20 AU AU2006326980A patent/AU2006326980B2/en active Active
- 2006-12-20 EP EP06830756A patent/EP1968949B1/de active Active
- 2006-12-20 DK DK06830756.0T patent/DK1968949T3/da active
- 2006-12-20 TW TW095148016A patent/TWI411608B/zh not_active IP Right Cessation
- 2006-12-20 PT PT06830756T patent/PT1968949E/pt unknown
- 2006-12-20 DE DE602006017743T patent/DE602006017743D1/de active Active
- 2006-12-20 AT AT06830756T patent/ATE485279T1/de active
- 2006-12-20 ES ES06830756T patent/ES2355045T3/es active Active
- 2006-12-20 PL PL06830756T patent/PL1968949T3/pl unknown
- 2006-12-20 KR KR1020087017836A patent/KR101411961B1/ko active IP Right Grant
- 2006-12-20 RU RU2008129637/04A patent/RU2425827C2/ru active
- 2006-12-20 BR BRPI0620150-4A patent/BRPI0620150A2/pt not_active Application Discontinuation
- 2006-12-20 JP JP2008546456A patent/JP5317702B2/ja active Active
- 2006-12-20 WO PCT/EP2006/070034 patent/WO2007071743A1/en active Application Filing
- 2006-12-20 AR ARP060105633A patent/AR058571A1/es not_active Application Discontinuation
- 2006-12-20 NZ NZ569636A patent/NZ569636A/en unknown
- 2006-12-20 SI SI200630879T patent/SI1968949T1/sl unknown
- 2006-12-20 CN CN2006800488945A patent/CN101346355B/zh active Active
- 2006-12-21 US US11/614,299 patent/US7880016B2/en active Active
-
2008
- 2008-05-15 ZA ZA200804198A patent/ZA200804198B/xx unknown
- 2008-06-17 IL IL192242A patent/IL192242A/en active IP Right Grant
-
2011
- 2011-01-14 CY CY20111100047T patent/CY1111113T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2632310A1 (en) | 2007-06-28 |
KR20080081179A (ko) | 2008-09-08 |
CY1111113T1 (el) | 2015-06-11 |
TW200740791A (en) | 2007-11-01 |
DE102005061624A1 (de) | 2007-06-28 |
JP5317702B2 (ja) | 2013-10-16 |
CN101346355A (zh) | 2009-01-14 |
ZA200804198B (en) | 2009-04-29 |
EP1968949A1 (de) | 2008-09-17 |
EP1968949B1 (de) | 2010-10-20 |
AU2006326980B2 (en) | 2012-07-05 |
CA2632310C (en) | 2014-02-11 |
IL192242A0 (en) | 2008-12-29 |
KR101411961B1 (ko) | 2014-06-27 |
BRPI0620150A2 (pt) | 2011-11-01 |
ES2355045T3 (es) | 2011-03-22 |
PT1968949E (pt) | 2010-12-22 |
IL192242A (en) | 2012-02-29 |
DE602006017743D1 (de) | 2010-12-02 |
RU2425827C2 (ru) | 2011-08-10 |
WO2007071743A1 (en) | 2007-06-28 |
AU2006326980A1 (en) | 2007-06-28 |
SI1968949T1 (sl) | 2011-02-28 |
CN101346355B (zh) | 2012-09-05 |
PL1968949T3 (pl) | 2011-04-29 |
JP2009520766A (ja) | 2009-05-28 |
NZ569636A (en) | 2010-04-30 |
RU2008129637A (ru) | 2010-01-27 |
US7880016B2 (en) | 2011-02-01 |
AR058571A1 (es) | 2008-02-13 |
DK1968949T3 (da) | 2011-01-24 |
US20070185173A1 (en) | 2007-08-09 |
TWI411608B (zh) | 2013-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE485279T1 (de) | Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden | |
DE502006001614D1 (de) | Verfahren zur herstellung von 1-alkyl-3-phenyluracilen | |
ATE516816T1 (de) | Verfahren zur herstellung von impfstoffen | |
DE502005010038D1 (de) | Verfahren zur herstellung von 3-pentennitril | |
DE602005009866D1 (de) | Verfahren zur herstellung von n-phenylpyrazol-1-carboxamiden | |
DE602005018601D1 (de) | Verfahren zur herstellung von 2-aminothiazol-5-aro | |
DE502005002059D1 (de) | Verfahren zur herstellung von polyetheralkoholen | |
DE602005019848D1 (de) | Verfahren zur herstellung von tad- getrocknetem ti | |
ATE554658T1 (de) | Verfahren zur herstellung von blatttee | |
ATE533747T1 (de) | Verfahren zur herstellung von tetrahydrochinolinderivaten | |
DE602006010302D1 (de) | Verfahren zur Herstellung von 5-methyl-2-furfural | |
DE602007009096D1 (de) | Verfahren zur herstellung von benzopyran-2-olderivaten | |
DE602005023438D1 (de) | Verfahren zur herstellung von polyestern | |
DE602006009562D1 (de) | Verfahren zur herstellung von ferrisuccinylcasein | |
ATE546436T1 (de) | Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten | |
DE602006008306D1 (de) | Verfahren zur herstellung von l-threonin | |
DE602005017099D1 (de) | Verfahren zur Herstellung von amorphem Cefuroximaxetil | |
DE602005021110D1 (de) | Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten | |
DE502006004187D1 (de) | Verfahren zur herstellung von diorganopolysiloxanen | |
ATE542533T1 (de) | Verfahren zur herstellung von isothiazol- derivaten | |
DE602005014035D1 (de) | Verfahren zur Herstellung von Aminen | |
DE602006018182D1 (de) | Verfahren zur herstellung von aralkyloxypyrrolidinderivaten | |
DE502006002029D1 (de) | Verfahren zur herstellung von polyetheraminen | |
DE602006017671D1 (de) | Verfahren zur herstellung von tricarbonsäuretris(alkylsubstituiertes cyclohexylamid) | |
DE602006015700D1 (de) | Neues verfahren zur herstellung von 5-amino-3h-thiazoloä4,5-düpyrimidin-2-on |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1968949 Country of ref document: EP |